I will add RLF100 yes has potential, and if actually developed and trialed as an inhaler could yield benefits.
RLFTF as a company is complete garbage, 3.2B Outstanding shares, that is up 1B more from last year, with a 1.6B Market Cap. Only good for trading pennies, no upside potential, diluted more than my dad's koollaid and a float big enough for a fleet of Chinese tankers.